Phone : 1-415-349-0054 Toll Free : 1-888-202-9519 Email : sales @ radiantinsights . com Web : http :// www . radiantinsights . com /
Table 14 : Type 2 Diabetes Mellitus , Global Pipeline Programs Targeting Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha , 2016 62 Table 15 : Type 2 Diabetes Mellitus , Global , Key Features of Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha , 2016 62 Table 16 : Type 2 Diabetes Mellitus , Global , Pipeline Programs Targeting Glucagon , 2016 63
List of Figures :
Figure 1 : Type 2 Diabetes Mellitus , Global , Innovation Trends in Product Approvals Across the Pharmaceutical Market , 1987-2014 6 Figure 2 : Type 2 Diabetes Mellitus , Global , Post-Marketing-Approval Sales Performance of Firstin-Class and Non-First-in-Class Products Across Pharmaceutical Industry ($ m ), 2006-2013 8 Figure 3 : Type 2 Diabetes Mellitus , Global , Marketed Products by Molecule Type , 2016 22 Figure 4 : Type 2 Diabetes Mellitus , Global , Marketed Products by Molecular Target , 2016 23 Figure 5 : Type 2 Diabetes Mellitus , Global , Pipeline Size by Therapy Area , 2016 25 Figure 6 : Type 2 Diabetes Mellitus , Global , Pipeline by Stage of Development and Molecule Type , 2016 26 Figure 7 : Type 2 Diabetes Mellitus , Global , Pipeline by Molecular Target and Stage of Development , 2016 27 Figure 8 : Type 2 Diabetes Mellitus , Global , Pipeline Breakdown of GPCR and Protein Kinase Molecular Target , 2016 28 Figure 9 : Type 2 Diabetes Mellitus , Global , Distribution of Pipeline and Marketed Products by Molecular Target Class , 2016 29 Figure 10 : Type 2 Diabetes Mellitus , Global , Distribution of Pipeline Products by First-in-Class Status and Molecular Target Class , 2016 31 Figure 11 : Type 2 Diabetes Mellitus , Global , Percentage Distribution of First-in-Class and Non- First-in-Class Pipeline Products by Stage of Development , 2016 32 Figure 12 : Type 2 Diabetes Mellitus , Global , Percentage Distribution of First-in-Class and Non- First-in-Class Pipeline Products by Molecular Target Class , 2016 32 Figure 13 : Type 2 Diabetes Mellitus , Global , Ratio of First-in-Class Targets to First-in-Class Products by Stage of Development , 2016 33 Figure 14 : Type 2 Diabetes Mellitus , Global , Ratio of First-in-Class Targets to First-in-Class Products by Molecular Target , 2016 33
Browse Full Research Report @ http :// www . radiantinsights . com / research / frontier-pharmatype-2-diabetes-mellitus-gpcrs-and-protein-kinases-dominate-pipeline
https
:// www . facebook . com / RadiantInsights
https :// www . linkedin . com / company / radiant-insights https :// twitter . com / radiantinsights
https :// plus . google . com /+ Radiantinsights